Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells
Peralta-Garcia, A.; Torrens-Fontanals, M.; Stepniewski, T.M.; Grau-Expósito, J.; Perea, D.; Ayinampudi, V.; Waldhoer, M.; Zimmermann, M.; Buzón, M.J.; Genescà, M.; Selent, J. Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. Int. J. Mol. Sci. 2021, 22, 13592. https://doi.org/10.3390/ijms222413592
Peralta-Garcia A, Torrens-Fontanals M, Stepniewski TM, Grau-Expósito J, Perea D, Ayinampudi V, Waldhoer M, Zimmermann M, Buzón MJ, Genescà M, Selent J. Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. International Journal of Molecular Sciences. 2021; 22(24):13592. https://doi.org/10.3390/ijms222413592
Chicago/Turabian StylePeralta-Garcia, Alejandro, Mariona Torrens-Fontanals, Tomasz M. Stepniewski, Judith Grau-Expósito, David Perea, Vikram Ayinampudi, Maria Waldhoer, Mirjam Zimmermann, María J. Buzón, Meritxell Genescà, and Jana Selent. 2021. "Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells" International Journal of Molecular Sciences 22, no. 24: 13592. https://doi.org/10.3390/ijms222413592